Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity
1. KMB announced acquisition of Kenvue, valued at $48.7 billion. 2. Kenvue faces legal issues regarding Tylenol's safety for pregnant women. 3. Shareholder concerns stem from Kenvue's branding and legal controversies. 4. KMB stock shows a potential positive price delta targeting $107.10. 5. Bull call spread offers high profit potential for aggressive traders.